- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
3164
TAI
Week ended 07 Aug 2026
Weekly Investor Report
GenMont Biotech Incorporation · Healthcare · Biotechnology
Latest close
16.40 TWD
-0.6%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -3.7% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned -0.6%, after a -0.3% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
16.40 TWD
7 Aug 2026
1W Return
-0.6%
latest completed week
4W Return
-0.3%
short-term follow-through
12W Return
-3.8%
quarterly tape
Trend Breadth
3.8%
2 of 52 weeks active
Volume Ratio
0.4x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-0.6%
Latest completed week; four-week move -0.3%.
Indicator stack
2/38
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 41.66%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -3.7% below the Trend Line and sits at 12.6% of its 52-week range. The latest completed week returned -0.6%, after a -0.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.4x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0312-week average 0.13
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.03Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -0.3% over four weeks, -3.8% over 12 weeks, and -15.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year2
Trend breadth3.8%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.80Latest activity-pressure read.
Pressure change25.3%Four-week change in activity pressure.
Leadership-32.78Latest relative-leadership reading.
RS change14.6%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-17.4%Distance below the 52-week high.
13-week volatility1.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher12 of 2614 weeks finished lower.
Best week+2.5%Week of 3 Jul.
Worst week-3.0%Week of 26 Jun.
Latest week-0.6%Week of 7 Aug.
Shape of recent returns
Strong gains0
Modest gains12
Flat weeks0
Modest losses14
Sharp losses0
Recent vol1.4%13-week weekly-return volatility.
Base vol1.2%52-week weekly-return volatility.
Up/down split17/31Count of positive and negative weeks in the 52-week window.
Average skew1.1% / -1.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank22 / 55
Group average-3.9%
Trend breadth30.9%
Trend30.9%active weekly trend signals
MD56.4%positive activity pressure
RS7.3%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank7 / 19
Group average-6.3%
Trend breadth31.6%
Trend31.6%active weekly trend signals
MD47.4%positive activity pressure
RS10.5%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape23/100
Trend, activity pressure, participation, and risk combine to a 23/100 tape read.
Indicator analysis12/100Latest 12-week confirmation: trend 0/12, activity pressure 2/12, relative leadership 0/12.
Activity pressure 0.03; No reversal markers Next-Week ExpectancyNegative 41.66%Next-week expectancy is negative with a 41.66% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 16.40 TWD | -0.6% | 17.03 TWD | 19.50 TWD | -0.80 | -32.78 | 126.9K | Off |
| 31 Jul 2026 | 16.50 TWD | 0.6% | 17.07 TWD | 19.54 TWD | -0.86 | -31.72 | 171.4K | Off |
| 24 Jul 2026 | 16.40 TWD | 0.6% | 17.11 TWD | 19.58 TWD | -0.97 | -34.05 | 116.9K | Off |
| 17 Jul 2026 | 16.30 TWD | -0.9% | 17.14 TWD | 19.61 TWD | -1.02 | -34.04 | 148.1K | Off |
| 10 Jul 2026 | 16.45 TWD | 0.9% | 17.18 TWD | 19.65 TWD | -1.07 | -38.38 | 205.1K | Off |
| 3 Jul 2026 | 16.30 TWD | 2.5% | 17.22 TWD | 19.69 TWD | -1.02 | -41.78 | 145.3K | Off |
| 26 Jun 2026 | 15.90 TWD | -3.0% | 17.27 TWD | 19.73 TWD | -0.93 | -41.38 | 376.5K | Off |
| 19 Jun 2026 | 16.40 TWD | 0.3% | 17.32 TWD | 19.77 TWD | -0.71 | -42.91 | 138.1K | Off |
| 12 Jun 2026 | 16.35 TWD | -0.9% | 17.37 TWD | 19.82 TWD | -0.40 | -41.07 | 518.0K | Off |
| 5 Jun 2026 | 16.50 TWD | -0.6% | 17.41 TWD | 19.86 TWD | -0.15 | -42.65 | 364.3K | Off |
| 29 May 2026 | 16.60 TWD | -1.2% | 17.46 TWD | 19.90 TWD | 0.13 | -42.83 | 541.9K | Off |
| 22 May 2026 | 16.80 TWD | -1.5% | 17.51 TWD | 19.95 TWD | 0.43 | -39.74 | 541.3K | Off |
| 15 May 2026 | 17.05 TWD | -2.0% | 17.55 TWD | 19.98 TWD | 0.71 | -38.10 | 432.8K | Off |
| 8 May 2026 | 17.40 TWD | -1.7% | 17.59 TWD | 20.01 TWD | 0.91 | -38.39 | 273.6K | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.